
Oxford Nanopore Technologies is seeking an experienced, field-based commercial professional to drive adoption and growth of Oxford Nanopore sequencing technologies across Western Canada, including British Columbia, Alberta, Saskatchewan, and Manitoba.
This is an exciting opportunity for an accomplished account executive who enjoys working at the intersection of science and commercial strategy. You will build relationships across complex scientific organizations, develop high-value accounts, and help customers evaluate and adopt Oxford Nanopore technologies to advance their research.
You will be responsible for growing adoption of our GridION and PromethION platforms across academic, government, biotechnology, and clinical research-focused organizations. Success in this role requires strong strategic account planning, technical fluency, commercial judgment, and the ability to navigate sophisticated evaluation and purchasing processes.
This is a remote, field-based position. Candidates must be based in Vancouver, British Columbia, Calgary, Alberta, or the surrounding areas.
What You’ll Do
What You’ll Bring
About the Opportunity
This role offers the opportunity to shape Oxford Nanopore’s continued growth across an important and diverse scientific market. You will have the autonomy to develop your territory while working alongside technical and commercial colleagues to help researchers and organizations unlock new possibilities through nanopore sequencing.
AI Disclosure: There is currently no legal requirement to disclose the use of artificial intelligence in recruitment or selection processes. However, based on recent guidelines and anticipated developments from the Office of the Privacy Commissioner of Canada, it is considered best practice to provide such notice in all postings.
Recordkeeping: Employers must ensure that any personal information held on another person (ex. employee or candidate) is up to date and accurate when used to make a decision in relation to the person concerned. The information used to make such a decision must be kept for at least one (1) year following the decision.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, color, age, disability, sexual orientation, or any other protected ground under applicable human rights legislation. Every candidate will be assessed only in accordance with their merits and qualifications.
he salary for this role is between $125,000 and $156,600 CAD. The salary offered will reflect the skills and experience of the candidate.
Certain roles within ONT are eligible annual bonus and stock. These awards are allocated based on individual performance.
#LI-Remote #LI-SH1
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.

Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.